SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ROIV
5. AAPL
6. ACN
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
(NASDAQ: SPRC) Delayed: 5.15 -0.14 (2.65%)
Previous Close $5.29    52 Week High $ 
Open $5.18    52 Week Low $ 
Day High $5.35    P/E N/A 
Day Low $5.06    EPS $ 
Volume 5,003       

(NASDAQ: SPRC) Delayed: 5.15 -0.14 (2.65%)
Previous Close $5.29    52 Week High $ 
Open $5.18    52 Week Low $ 
Day High $5.35    P/E N/A 
Day Low $5.06    EPS $ 
Volume 5,003